JAK2 and Stroke: It has been shown recently that pretreatment with a Jak2 inhibitor (AG490) in a rodent stroke model alleviated brain endothelial cell barrier disruption and decreased the reduction of tight junction ZO-1 protein caused by IL-6 [43].